Ultra-processed Foods for Cardiometabolic Health
(NOVA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how various aspects of ultra-processed foods impact heart and metabolic health. Researchers aim to determine whether the nutrients in these foods, such as high sugar and salt, are harmful, or if the processing methods are the primary concern. Participants will consume specially provided meals to assist in this investigation. Ideal candidates maintain a stable weight, have normal blood pressure, and do not smoke heavily or have major health issues. As an unphased study, this trial offers a unique opportunity to contribute to groundbreaking research on diet and health.
Will I have to stop taking my current medications?
If you are taking medication for high cholesterol, diabetes, or high blood pressure, you cannot participate in this trial. The protocol does not specify about other medications, so it's best to discuss with the trial team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that consuming a lot of ultra-processed foods (UPFs) can harm health, particularly the heart and metabolism. Studies have found that diets high in UPFs often contain lower-quality nutrients and more added sugars and unhealthy fats, increasing the risk of obesity, heart disease, and even early death. Some reports suggest that eating more UPFs can raise the risk of heart and metabolic issues by 25% to 58%.
However, not all UPFs affect health in the same way. The risk can vary depending on the specific nutrients and the degree of processing. This trial aims to explore these differences further. While UPFs are common in many diets, understanding their impact is key to making healthier choices. Participants in this study will help identify which aspects of UPFs are most harmful.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different combinations of nutrients and processing levels in ultra-processed foods might impact cardiometabolic health. Unlike traditional treatments for cardiometabolic conditions that often involve medications or lifestyle changes, this trial focuses on dietary interventions. The trial investigates four different diets: Diet N-P+, Diet N+P+, Diet N-P-, and Diet N+P-, each varying in nutrient and processing content. This approach could help identify specific dietary patterns that either benefit or harm heart and metabolic health, offering potential new dietary guidelines tailored to improve health outcomes.
What evidence suggests that this trial's treatments could be effective for cardiometabolic health?
This trial will explore the impact of different diets involving ultra-processed foods (UPFs) on cardiometabolic health. Studies have shown a strong link between consuming UPFs and a higher risk of heart and metabolic health problems. People who consume many UPFs have a 25% to 58% higher chance of developing these issues compared to those who consume fewer. Research also indicates that diets high in UPFs usually contain more added sugars, unhealthy fats, and salt, which can harm heart health. Specifically, for every 10% increase in UPF intake, the risk of heart disease rises by 12%. These findings suggest that both the ingredients and the processing of UPFs might contribute to these risks.12356
Who Is on the Research Team?
Benoît Lamarche, PhD
Principal Investigator
Laval University
Are You a Good Fit for This Trial?
This trial is for men and women who are at risk of heart disease and diabetes (cardiometabolic risk). Participants will be eating specific diets provided by the study for 6 weeks. People with dietary restrictions or health conditions that could interfere with the diet or results may not qualify.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume one of four experimental diets for 6 weeks, with meals provided under isocaloric conditions to maintain body weight constant.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with measurements of cardiometabolic risk factors.
What Are the Treatments Tested in This Trial?
Interventions
- Ultra-processed Foods
Find a Clinic Near You
Who Is Running the Clinical Trial?
Laval University
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator